Working Papers

Filter By:



Research Team

Use comma-separated ID numbers for each author

Support the Hoover Institution

Join the Hoover Institution's community of supporters in advancing ideas defining a free society.

Support Hoover

Patents are the Foundation of the Market for Inventions

by Daniel F. Spulbervia IP2 Working Paper Series
Monday, April 21, 2014

IP² Working Paper No. 14009 - The paper develops a comprehensive framework demonstrating that patents provide the foundation for the market for inventions.

Understanding the Realities of Modern Patent Litigation

by John R. Allison, Mark A. Lemley, David L. Schwartzvia IP2 Working Paper Series
Wednesday, April 16, 2014

IP² Working Paper No. 14008 - Sixteen years ago, two of us published the first detailed empirical look at patent litigation. That study provided a wealth of valuable information about patent validity litigation, including the discovery that nearly half of all patents litigated to judgment were held invalid. 

Does Compulsory Licensing Discourage Invention? Evidence from Patents after the US Trading-with-the-Enemy Act

by Joerg Baten, Petra Moservia IP2 Working Paper Series
Wednesday, April 16, 2014

IP² Working Paper No. 14007 - Compulsory licensing – which allows patents to be licensed without the consent of patent owners – is a prominent mechanism to improve access to essential innovations, such as medicines to combat HIV. 

Smart Phone Litigation and Standard Essential Patents

by Kirti Gupta, Mark Snydervia IP2 Working Paper Series
Wednesday, April 16, 2014

IP² Working Paper No. 14006 - The recent sensationalizing of litigation in the smart phone industry has fostered several concerns, in particular those relating directly to the so-called standard essential patents (SEPs).

Do Firms Underinvest in Long-Term Research? Evidence from Cancer Clinical Trials

by Eric Budish, Benjamin N. Roin, Heidi Williamsvia IP2 Working Paper Series
Wednesday, March 12, 2014

IP² Working Paper No. 14005 - Patents award innovators a fixed period of market exclusivity, e.g., 20 years in the United States. Yet, since in many industries firms file patents at the time of discovery (“invention”) rather than first sale (“commercialization”), effective patent terms vary: inventions that commercialize at the time of invention receive a full patent term, whereas inventions that have a long time lag between invention and commercialization receive substantially reduced – or in extreme cases, zero – effective patent terms.

Commentary: Monetary Policy after the Fall

by John B. Taylorvia Economics Working Papers
Saturday, August 28, 2010

Economics Working Paper WP10106

Politics and the Fed

by Allan H. Meltzervia Economics Working Papers
Monday, March 1, 2010

Economics Working Paper WP10102